SCHEMBL11922025

SCHEMBL11922025

Cn1c2ccccc2c2ccc(N(c3ccccc3)c3ccc(-c4ccc(N(c5ccccc5)c5ccc6c(c5)C(C)(C)c5ccccc5-6)cc4)cc3)cc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXRA P19793 1/20 0.42
▸ RXRB P28702 1/20 0.42
▸ KDM4E B2RXH2 4/20 0.38
▸ HPGD P15428 4/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ HSD17B10 Q99714 3/20 0.38
▸ GPR3 P46089 1/20 0.36
▸ KIF11 P52732 1/20 0.35
▸ MAPT P10636 4/20 0.33
▸ NPC1 O15118 3/20 0.33
▸ RAB9A P51151 3/20 0.33
▸ PDK2 Q15119 2/20 0.33
▸ LMNA P02545 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ PABPC1 P11940 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ GSK3B P49841 1/20 0.33
▸ PSEN1 P49768 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11922081 0.93 RXRA (0.38) RXRARXRBKDM4EHPGDALDH1A1
SCHEMBL25563043 0.92 KDM4E (0.37) RXRARXRBKDM4EHPGDALDH1A1
SCHEMBL21919222 0.91 RXRA (0.41) RXRARXRBKDM4EHPGDALDH1A1
SCHEMBL21919153 0.90 BCHE (0.36) RXRARXRBKDM4EHPGDALDH1A1
SCHEMBL25563376 0.89 RXRA (0.40) RXRARXRBKDM4EHPGDALDH1A1
SCHEMBL25563115 0.88 HSD17B10 (0.33) RXRARXRBKDM4EHPGDALDH1A1
SCHEMBL21919154 0.88 KDM4E (0.38) RXRARXRBKDM4EHPGDALDH1A1
SCHEMBL23660711 0.86 KDM4E (0.35) RXRARXRBKDM4EHPGDALDH1A1
SCHEMBL12116330 0.86 GPR3 (0.39) RXRARXRBKDM4EHPGDALDH1A1
SCHEMBL25563152 0.86 GPR3 (0.39) RXRARXRBKDM4EHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9650565-B2 Carbazole compound and use thereof TOSOH CORPORATION (JP) 2017-05-16 — — US disclosed
US-9650565-B2 Carbazole compound and use thereof TOSOH CORPORATION (JP) 2017-05-16 — — US disclosed
US-20120203010-A1 CARBAZOLE COMPOUND AND USE THEREOF TOSOH CORPORATION (JP) 2012-08-09 — — US disclosed
US-20120203010-A1 CARBAZOLE COMPOUND AND USE THEREOF TOSOH CORPORATION (JP) 2012-08-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120203010-A1 CARBAZOLE COMPOUND AND USE THEREOF AR, DRD3, AHR RXRA 568/4885RXRB 589/4885KDM4E 2681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback